Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

March 01, 1996; Volume 24,Issue 3
  • You have access
    Hepatic first-pass uptake of diphenhydramine. A comparative study between fetal and adult sheep.
    G R Tonn, E Kwan, C Hall, K W Riggs, J E Axelson and D W Rurak
    Drug Metabolism and Disposition March 1996, 24 (3) 273-281;
  • You have access
    Dose-related distribution of codeine and its metabolites into rat hair.
    S P Gygi, F Colon, R B Raftogianis, R E Galinsky, D G Wilkins and D E Rollins
    Drug Metabolism and Disposition March 1996, 24 (3) 282-287;
  • You have access
    Influence of the degree of renal dysfunction on the pharmacokinetic properties of the novel recombinant plasminogen activator reteplase in rats.
    U Martin, L Doerge, K Stegmeier and B Müller-Beckmann
    Drug Metabolism and Disposition March 1996, 24 (3) 288-292;
  • You have access
    Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
    M A Shirley, Y L Bennani, M F Boehm, A P Breau, C Pathirana and E H Ulm
    Drug Metabolism and Disposition March 1996, 24 (3) 293-302;
  • You have access
    A sensitive method for determination of cytochrome P4502D6 activity in vitro using bupranolol as substrate.
    G Appanna, B K Tang, R Mller and W Kalow
    Drug Metabolism and Disposition March 1996, 24 (3) 303-306;
  • You have access
    Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
    M Chiba, M Hensleigh, J A Nishime, S K Balani and J H Lin
    Drug Metabolism and Disposition March 1996, 24 (3) 307-314;
  • You have access
    Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits.
    K C Cundy, Z H Li and W A Lee
    Drug Metabolism and Disposition March 1996, 24 (3) 315-321;
  • You have access
    Characterization of rat small intestinal cytochrome P450 composition and inducibility.
    Q Y Zhang, J Wikoff, D Dunbar and L Kaminsky
    Drug Metabolism and Disposition March 1996, 24 (3) 322-328;
  • You have access
    Purification and properties of two rat liver phenobarbital-inducible UDP-glucuronosyltransferases that catalyze the glucuronidation of opioids.
    B L Coffman, G R Rios and T R Tephly
    Drug Metabolism and Disposition March 1996, 24 (3) 329-333;
  • You have access
    Metabolism and pharmacokinetics of N1,N14-diethylhomospermine.
    R J Bergeron, W R Weimar, G Luchetta, C A Sninsky and J Wiegand
    Drug Metabolism and Disposition March 1996, 24 (3) 334-343;
  • You have access
    CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells.
    L S Gan, M A Moseley, B Khosla, P F Augustijns, T P Bradshaw, R W Hendren and D R Thakker
    Drug Metabolism and Disposition March 1996, 24 (3) 344-349;
  • You have access
    Metoprolol metabolism via cytochrome P4502D6 in ethnic populations.
    J A Johnson and B S Burlew
    Drug Metabolism and Disposition March 1996, 24 (3) 350-355;
  • You have access
    Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein.
    M D Green and T R Tephly
    Drug Metabolism and Disposition March 1996, 24 (3) 356-363;
  • You have access
    Short-term maintenance of phase I and II metabolism in precision-cut liver slices in dynamic organ culture.
    S Ekins
    Drug Metabolism and Disposition March 1996, 24 (3) 364-366;
  • You have access
    Influence of age and gender on valproic acid glucuronidation in rats.
    C Chen, P W Slattum, K L Brouwer and G M Pollack
    Drug Metabolism and Disposition March 1996, 24 (3) 367-370;
  • You have access
    Interactions of melphalan with glutathione and the role of glutathione S-transferase.
    S Awasthi, K K Bajpai, J T Piper, S S Singhal, A Ballatore, W E Seifert, Y C Awasthi and G A Ansari
    Drug Metabolism and Disposition March 1996, 24 (3) 371-374;
  • You have access
    Effects of the novel immunosuppressant brequinar on hepatic UDP-glucuronic acid levels and UDP-glucuronyltransferase activities in the rat.
    S Diamond and D D Christ
    Drug Metabolism and Disposition March 1996, 24 (3) 375-376;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 24, Issue 3
1 Mar 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics